Evidence map›Paper›PMID 33116297›Full record

ArticleCell death and differentiation2021

YAP-TEAD1 control of cytoskeleton dynamics and intracellular tension guides human pluripotent stem cell mesoderm specification.

Stefania Pagliari, Vladimir Vinarsky, Fabiana Martino, Ana Rubina Perestrelo, Jorge Oliver De La Cruz, Guido Caluori, Jan Vrbsky, Pamela Mozetic, Antonio Pompeiano, Andrea Zancla and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 4 countries.

Stefania PagliariInternational Clinical Research Center (ICRC) of St Anne's University Hospital, CZ-65691, Brno, Czech Republic. stefania.pagliari@fnusa.cz.
Vladimir VinarskyInternational Clinical Research Center (ICRC) of St Anne's University Hospital, CZ-65691, Brno, Czech Republic.
Fabiana MartinoInternational Clinical Research Center (ICRC) of St Anne's University Hospital, CZ-65691, Brno, Czech Republic.
Ana Rubina PerestreloInternational Clinical Research Center (ICRC) of St Anne's University Hospital, CZ-65691, Brno, Czech Republic.
Jorge Oliver De La CruzInternational Clinical Research Center (ICRC) of St Anne's University Hospital, CZ-65691, Brno, Czech Republic.
Guido CaluoriInternational Clinical Research Center (ICRC) of St Anne's University Hospital, CZ-65691, Brno, Czech Republic.
Jan VrbskyInternational Clinical Research Center (ICRC) of St Anne's University Hospital, CZ-65691, Brno, Czech Republic.
Pamela MozeticInternational Clinical Research Center (ICRC) of St Anne's University Hospital, CZ-65691, Brno, Czech Republic.
Antonio PompeianoInternational Clinical Research Center (ICRC) of St Anne's University Hospital, CZ-65691, Brno, Czech Republic.
Andrea ZanclaUniversità Campus Bio-Medico di Roma, Rome, Italy.
Sri Ganji RanjaniCentral European Institute of Technology, Masaryk University, CZ-62500, Brno, Czech Republic.
Petr SkladalCentral European Institute of Technology, Masaryk University, CZ-62500, Brno, Czech Republic.
Dan KytyrCzech Academy of Sciences, Institute of Theoretical and Applied Mechanics, 190 00, Prague 9, Czech Republic.ORCID http://orcid.org/0000-0001-7439-0580
Zbyněk ZdráhalCentral European Institute of Technology, Masaryk University, CZ-62500, Brno, Czech Republic.
Gabriele GrassiDepartment of Life Sciences, Cattinara University Hospital, Trieste University, I-34149, Trieste, Italy.
Maurilio SampaolesiDepartment of Development and Regeneration, KU Leuven, 3000, Leuven, Belgium.
Alberto RainerUniversità Campus Bio-Medico di Roma, Rome, Italy.
Giancarlo ForteInternational Clinical Research Center (ICRC) of St Anne's University Hospital, CZ-65691, Brno, Czech Republic. giancarlo.forte@fnusa.cz.ORCID http://orcid.org/0000-0002-1341-1023
International Clinical Research Center, St. Anne's University Hospital Brno · CZCentral European Institute of Technology · CZUniversità Campus Bio-Medico · ITCzech Academy of Sciences, Institute of Theoretical and Applied Mechanics · CZKU Leuven · BEMasaryk University · CZUniversity of Turku · FI

Funding

EC | Directorate-General for Employment, Social Affairs and Inclusion | European Social Fund (Fondo Social Europeo) CZ.02.1.01/0.0/0.0/15_003/0000492
6 · The paper itself

Abstract

The tight regulation of cytoskeleton dynamics is required for a number of cellular processes, including migration, division and differentiation. YAP-TEAD respond to cell-cell interaction and to substrate mechanics and, among their downstream effects, prompt focal adhesion (FA) gene transcription, thus contributing to FA-cytoskeleton stability. This activity is key to the definition of adult cell mechanical properties and function. Its regulation and role in pluripotent stem cells are poorly understood. Human PSCs display a sustained basal YAP-driven transcriptional activity despite they grow in very dense colonies, indicating these cells are insensitive to contact inhibition. PSC inability to perceive cell-cell interactions can be restored by tampering with Tankyrase enzyme, thus favouring AMOT inhibition of YAP function. YAP-TEAD complex is promptly inactivated when germ layers are specified, and this event is needed to adjust PSC mechanical properties in response to physiological substrate stiffness. By providing evidence that YAP-TEAD1 complex targets key genes encoding for proteins involved in cytoskeleton dynamics, we suggest that substrate mechanics can direct PSC specification by influencing cytoskeleton arrangement and intracellular tension. We propose an aberrant activation of YAP-TEAD1 axis alters PSC potency by inhibiting cytoskeleton dynamics, thus paralyzing the changes in shape requested for the acquisition of the given phenotype.

Indexed as

Adaptor Proteins, Signal TransducingAngiomotinsCell DifferentiationCell LineCytoskeletonHuman Embryonic Stem CellsHumansMesodermProtein BindingSignal TransductionTEA Domain Transcription FactorsYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingAngiomotinsTEAD1 protein, humanTEA Domain Transcription FactorsYAP1 protein, humanYAP-Signaling Proteins

Identifiers

PMID33116297
PMCPMC8027678
OpenAlexW3096482900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.